Načítá se...
Cardioembolic stroke: everything has changed
Historically, because of the difficulty of using warfarin safely and effectively, many patients with cardioembolic stroke who should have been anticoagulated were instead given ineffective antiplatelet therapy (or no antithrombotic therapy). With the arrival of new oral anticoagulants that are not s...
Uloženo v:
| Vydáno v: | Stroke Vasc Neurol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047338/ https://ncbi.nlm.nih.gov/pubmed/30022801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2018-000143 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|